, Malaysia
447 views
Photo by Ksenia Chernaya via Pexels

ISEC unit partners for new Malaysian ophthalmology centre

The joint venture company will have an issued share capital of $30.

ISEC Healthcare Ltd. has announced that its Malaysian subsidiary has entered into a joint venture (JV) agreement with Bond Infinity Sdn. Bhd. (Bond Infinity) for an ophthalmology centre in the country.

In a bourse filing, the company said ISEC Sdn. Bhd. (ISEC Malaysia) signed the agreement. The subsidiary and Bond Infinity will incorporate a joint venture company under the proposed name of ISEC (Seremban) Sdn. Bhd. which will establish, operate, and administer an ophthalmology centre in the city of Seremban, State of Negeri Sembilan.

The centre will provide medical consultations and services, subject to all requisite approvals, licenses and permits as required under the Private Healthcare and Facilities Act 1998 of Malaysia.

The JV company's issued share capital upon incorporation shall be $30 (RM100) comprising 100 ordinary shares.

Investment in the ophthalmology centre will be funded by internal resources. It is not expected to have any material impact on the consolidated net tangible assets per share or earnings per share of ISEC Healthcare for the current financial year ending 31 December 2025.

Join Singapore Business Review community
Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.